News for Aion Therapeutic Inc. (ANTCF)

Aion Therapeutic Inc. is pleased to announce that it has completed a non-brokered private placement offering of 50,000,000 units , at a price of $0.015 per Unit, for total gross proceeds of...

Aion Therapeutic Inc. is pleased to announce that it plans to complete a non-brokered private placement offering of up to 50,000,000 units , at a price of $0.015 per Unit, for total gross proceeds...

Toronto, Ontario - October 23, 2023 (Newsfile Corp.) (Investorideas.com Newswire) Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is ple...

Aion Therapeutic Inc. is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure... | November 2, 2021

Aion Therapeutic Inc. announces that further to its press release dated September 14, 2021, the Company is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203").

Aion Therapeutic Inc. is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults.

To date, 74% of prescription drugs are derived from plants, 18% specifically from fungi. Still, many companies hesitate to invest in the medicinal ...

Logo alt=Aion Therapeutic Inc. - Logo /> Dr. De La Haye will be speaking on, Psychedelics, the New Frontier in Psychiatry, revealing for the first...

Aion Therapeutic Inc. is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units at a price of $0.0875 per Unit for gross proceeds of... | June 11, 2021